SYRE Spyre Therapeutics, Inc. logo

SYRE Spyre Therapeutics, Inc.

Healthcare
$74.05-0.36%ClosedMarket Cap: $4.47B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

156

13F Shares

80,976,878

Ownership %

108.1%

New Positions

30

Increased Positions

107

Closed Positions

14

Reduced Positions

27

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SBIOALPS Medical Breakthroughs ETF63,9392.47%
XBI1,069,5560.70%
DWASInvesco Dorsey Wright SmallCap Momentum ETF40,3320.53%
LABUDirexion Daily S&P Biotech Bull 3X ETF53,5550.51%
OPTZOptimize Strategy Index ETF25,7860.40%
IBBiShares Biotechnology ETF478,9090.28%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF21,9960.16%
NLO377,7780.15%
IWOiShares Russell 2000 Growth ETF377,7780.15%
VTWG42,3350.13%
IWMiShares Russell 2000 ETF1,685,5610.11%
NJM1,685,5610.11%
RSSLGlobal X - Russell 2000 ETF31,5700.10%
VTWO341,3190.10%
SCHASchwab U.S. Small-Cap ETF330,3250.08%
IWNiShares Russell 2000 Value ETF194,9760.07%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF12,5830.07%
NAJ194,9760.07%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF31,8340.07%
VTWV17,1630.07%